Availability and payer coverage of BRCA1/2 tests and gene panels

Nat Biotechnol. 2015 Sep;33(9):900-2. doi: 10.1038/nbt.3322.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Biomarkers, Tumor / genetics
  • Genetic Markers / genetics
  • Health Services Accessibility / economics*
  • Health Services Accessibility / statistics & numerical data
  • High-Throughput Screening Assays / economics*
  • High-Throughput Screening Assays / statistics & numerical data*
  • Humans
  • Insurance, Health, Reimbursement / economics*
  • Multigene Family / genetics
  • Neoplasms / diagnosis
  • Neoplasms / economics*
  • Neoplasms / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • United States

Substances

  • BRCA1 Protein
  • BRCA2 Protein
  • BRCA2 protein, human
  • Biomarkers, Tumor
  • Genetic Markers